Regenerex Pharma Files 8-K on Officer/Director Changes
Ticker: RGPX · Form: 8-K · Filed: Dec 10, 2024 · CIK: 1357878
| Field | Detail |
|---|---|
| Company | Regenerex Pharma, Inc. (RGPX) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election
TL;DR
Regenerex Pharma (RGXP) filed an 8-K detailing board and exec changes. Watch for new strategy.
AI Summary
Regenerex Pharma, Inc. filed an 8-K on December 10, 2024, reporting changes related to its directors and officers, including elections and appointments. The filing also covers compensatory arrangements for certain officers. The company, formerly known as Peptide Technologies, Inc. and Eternelle Skincare Products Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in leadership and compensatory arrangements can indicate internal shifts that may impact future performance.
Key Players & Entities
- REGENEREX PHARMA, INC. (company) — Registrant
- Peptide Technologies, Inc. (company) — Former Company Name
- Eternelle Skincare Products Inc. (company) — Former Company Name
- December 10, 2024 (date) — Report Date
FAQ
What specific changes were made regarding directors or officers?
The 8-K filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers'.
Does the filing detail any new compensatory arrangements?
Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers'.
When was this 8-K report filed?
The report was filed on December 10, 2024.
What is Regenerex Pharma, Inc.'s state of incorporation?
Regenerex Pharma, Inc. is incorporated in Nevada.
What industry does Regenerex Pharma, Inc. operate in?
Regenerex Pharma, Inc. operates in the Pharmaceutical Preparations sector (SIC code 2834).
Filing Stats: 701 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2024-12-10 17:12:45
Filing Documents
- ixform8k.htm (8-K) — 20KB
- 0001472375-24-000106.txt ( ) — 183KB
- rgpx-20241210.xsd (EX-101.SCH) — 3KB
- rgpx-20241210_lab.xml (EX-101.LAB) — 33KB
- rgpx-20241210_pre.xml (EX-101.PRE) — 22KB
- ixform8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized. REGENEREX PHARMA, INC. Date: December 10, 2024 By: /s/ Gregory Pilant Gregory Pilant Chief Executive Officer